Medically reviewed by Daniel More, MD Key Takeaways Asthma action plans help maintain good asthma control by outlining ...

DENVER — National Jewish Health researchers are looking for ways to identify patients with untreated mild persistent asthma who might benefit from daily inhaled treatment based on inflammatory ...

The BATURA trial ended early due to high efficacy data at pre-planned analysis. Topline results were announced from a phase 3b trial evaluating albuterol/budesonide metered dose inhaler in patients ...

Please provide your email address to receive an email when new articles are posted on . The treatment group had reductions in FeNO 1 week after a single dose. Reductions were significant compared with ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Please provide your email address to receive an email when new articles are posted on . Significantly fewer pediatric patients with low- vs. high-risk intermittent asthma had an ED visit and inhaled ...

Adolescents with overweight or obesity and asthma had a lower risk of asthma exacerbations after starting a GLP-1 receptor ...

High airway TSLP asthma is linked to severe disease, type 2 inflammation, and airway remodelling. Learn more about how TSLP may guide targeted treatment.

WILMINGTON, Del.--(BUSINESS WIRE)-- AIRSUPRA’s US Prescribing Information now includes clinically meaningful evidence from the BATURA study in patients with mild asthma. 1 The BATURA Phase IIIb trial, ...